| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; Lin K.-Y.; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; YU-SHAN HUANG; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:27Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
YU-SHAN HUANG; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Sun H.-Y.; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T06:05:06Z |
Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus
|
Wang J.-L.; Tang H.-J.; Hsieh P.-H.; Chiu F.-Y.; Chen Y.-H.; Chang M.-C.; Huang C.-T.; Liu C.-P.; Lau Y.-J.; Hwang K.-P.; Ko W.-C.; CHEN-TI WANG; Liu C.-Y.; Liu C.-L.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; HSIN-YUN SUN; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
Huang Y.-S.; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; HSIN-YUN SUN; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-16T08:36:11Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; ARISTINE CHENG; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-05-18T05:56:58Z |
Antimicrobial-resistant Nocardia isolates, Taiwan, 1998-2009
|
Lai C.-C.; Liu W.-L.; Ko W.-C.; Chen Y.-H.; Tang H.-J.; YU-TSUNG HUANG; Hsueh P.-R. |
| 臺大學術典藏 |
2021-05-18T05:56:51Z |
Clinical and microbiological characteristics of infections caused by various Nocardia species in Taiwan: A multicenter study from 1998 to 2010
|
Liu W.L.; Lai C.C.; Ko W.C.; Chen Y.H.; Tang H.J.; Huang Y.L.; YU-TSUNG HUANG; Hsueh P.R. |
| 臺大學術典藏 |
2021-05-06T08:25:56Z |
National surveillance of antimicrobial susceptibility of bacteremic gram-negative bacteria with emphasis on community-acquired resistant isolates: Report from the 2019 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Liu P.-Y.;Lee Y.-L.;Lu M.-C.;Pei-Lan Shao;Lu P.-L.;Chen Y.-H.;Cheng S.-H.;Ko W.-C.;Lin C.-Y.;Wu T.-S.;Yen M.-Y.;Wang L.-S.;Liu C.-P.;Lee W.-S.;Chen Y.-S.;Wang F.-D.;Tseng S.-H.;Lin C.-N.;Tang H.-J.;Chen Y.-H.;Sheng W.-H.;Lee C.-M.;Liao M.-H.;Hsueh P.-R.; Liu P.-Y.; Lee Y.-L.; Lu M.-C.; PEI-LAN SHAO; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Tang H.-J.; Chen Y.-H.; Sheng W.-H.; Lee C.-M.; Liao M.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-05-06T01:51:42Z |
Species identification and antifungal susceptibility of uncommon blood yeast isolates
|
Li M.-C.; Tang H.-J.; Wu C.-J.; Wang S.-W.; Su S.-L.; Liu W.-L.; Ko W.-C.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2021-05-06T01:25:13Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; CHIEN-CHING HUNG; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-05-06T01:25:11Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
Huang Y.-S.; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Sun H.-Y.; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; CHIEN-CHING HUNG; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-02-26T01:59:51Z |
Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis
|
Tsai H.-Y.;Chen Y.-H.;Tang H.-J.;Huang C.-C.;Liao C.-H.;Chu F.-Y.;Chuang Y.-C.;Wang-Huei Sheng;Ko W.-C.;Hsueh P.-R.; Tsai H.-Y.; Chen Y.-H.; Tang H.-J.; Huang C.-C.; Liao C.-H.; Chu F.-Y.; Chuang Y.-C.; WANG-HUEI SHENG; Ko W.-C.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-02-26T01:59:34Z |
Comparison of serological responses to single-dose azithromycin (2 g) versus benzathine penicillin G in the treatment of early syphilis in HIV-infected patients in an area of low prevalence of macrolide-resistant Treponema pallidum infection
|
Yang C.-J.; Tang H.-J.; Chang S.-Y.; Hsieh S.-M.; Lee K.-Y.; Lee Y.-T.; WANG-HUEI SHENG; Yang S.-P.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-02-26T01:59:32Z |
Antimicrobial activities of cefoperazone-sulbactam in comparison to cefoperazone against clinical organisms from medical centers in Taiwan
|
Chiang T.-T.;Tang H.-J.;Chiu C.-H.;Chen T.-L.;Ho M.-W.;Lee C.-H.;Wang-Huei Sheng;Yang Y.-S.; Chiang T.-T.; Tang H.-J.; Chiu C.-H.; Chen T.-L.; Ho M.-W.; Lee C.-H.; WANG-HUEI SHENG; Yang Y.-S. |
| 臺大學術典藏 |
2021-02-26T01:59:08Z |
National surveillance of antimicrobial susceptibility of bacteremic gram-negative bacteria with emphasis on community-acquired resistant isolates: Report from the 2019 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Liu P.-Y.; Lee Y.-L.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Tang H.-J.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Liao M.-H.; Hsueh P.-R. |
| 國立成功大學 |
2021 |
Molecular characteristics and in vitro effects of antimicrobial combinations on planktonic and biofilm forms of Elizabethkingia anophelis
|
Tang, H.-J.;Lin, Y.-T.;Chen, Chen C.-C.;Chen, Chen C.-W.;Lu, Y.-C.;Ko, W.-C.;Chen, H.-J.;Su, B.-A.;Chang, P.-C.;Chuang, Y.-C.;Lai, C.-C. |
| 國立成功大學 |
2021 |
Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia–Pacific region
|
Liao, C.-T.;Yang, C.-T.;Toh, H.S.;Chang, W.-T.;Chang, H.-Y.;Kuo, F.-H.;Lee, M.-C.;Hua, Y.-M.;Tang, H.-J.;Strong, C.;Ou, H.-T. |
| 國立成功大學 |
2021 |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin, J.-J.;Lin, K.-Y.;Tang, H.-J.;Lin, S.-P.;Lee, Y.-C.;Liu, C.-E.;Huang, Y.-S.;Wang, N.-C.;Li, C.-W.;Ko, W.-C.;Yang, H.-J.;Lee, Y.-T.;Hung, C.-C.;Group, Taiwan HIV Study |
| 國立成功大學 |
2021 |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou, B.-H.;Sun, H.-Y.;Yang, C.-J.;Syue, L.-S.;Lee, Y.-L.;Tang, H.-J.;Tsai, H.-C.;Lin, C.-Y.;Chen, T.-C.;Lee, C.-Y.;Huang, S.-H.;Liu, C.-W.;Lu, P.-L.;Lin, S.-P.;Wang, N.-C.;Cheng, A.;Ko, W.-C.;Cheng, S.-H.;Hung, C.-C.;Group, the Taiwan HIV Study |
| 國立成功大學 |
2021 |
Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study
|
Huang, S.-H.;Lee, C.-Y.;Tsai, C.-S.;Tsai, M.-S.;Liu, C.-E.;Hsu, W.-T.;Chen, H.-A.;Liu, W.-D.;Yang, C.-J.;Sun, H.-Y.;Ko, W.-C.;Lu, P.-L.;Lee, Y.-T.;Hung, C.-C.;Sun, H.-Y.;Huang, Y.-S.;Chang, S.-Y.;Wu, P.-Y.;Chen, L.-Y.;Zhang, J.-Y.;Chang, H.-Y.;Liu, W.-C.;Su, Y.-C.;Hung, C.-C.;Wang, N.-C.;Lin, T.-Y.;Lin, K.-Y.;Yang, C.-J.;Chen, H.-A.;Tsai, M.-S.;Lee, Y.-C.;Cheng, Cheng C.-Y.;Cheng, S.-H.;Huang, Y.-C.;Huang, S.-H.;Lee, Y.-T.;Lin, J.-J.;Lin, S.-P.;Hsieh, C.-Y.;Wang, H.-W.;Ho, M.-W.;Liu, C.-E.;Lee, Y.-L.;Chen, G.-J.;Lin, C.-Y.;Hung, T.-C.;Tang, H.-J.;Ku, H.-C.;Li, C.-W.;Tsai, C.-S.;Lee, N.-Y.;Ko, W.-C.;Lu, P.-L.;Lee, C.-Y.;Chen, Y.-H.;Lee, C.-H.;Tsai, H.-C.;Che, T.-C.;Group, Taiwan HIV Study |
| 國立成功大學 |
2021 |
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistan
|
Lee, Y.-L.;Ko, W.-C.;Lee, W.-S.;Lu, P.-L.;Chen, Y.-H.;Cheng, S.-H.;Lu, M.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Shao, P.-L.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Tang, H.-J.;Hsueh, P.-R. |
| 國立成功大學 |
2021 |
Hydrodynamic behaviors of aquaculture net cages after the successive mooring lines failure
|
Tang, H.-J.;Yang, R.-Y. |
| 臺大學術典藏 |
2020-12-29T05:33:48Z |
Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan
|
Li C.-W.;Yang C.-J.;Hsin-Yun Sun;Tsai M.-S.;Lin S.-P.;Lin T.-Y.;Cheng C.-Y.;Lee Y.-C.;Huang Y.-S.;Liu C.-E.;Lee Y.-T.;Tang H.-J.;Wang N.-C.;Cheng S.-H.;Ko W.-C.;Hung C.-C.; Hung C.-C.; Ko W.-C.; Cheng S.-H.; Tang H.-J.; Wang N.-C.; Lee Y.-T.; Li C.-W.; Yang C.-J.; HSIN-YUN SUN; Tsai M.-S.; Lin S.-P.; Lin T.-Y.; Cheng C.-Y.; Lee Y.-C.; Huang Y.-S.; Liu C.-E. |
| 臺大學術典藏 |
2020-12-29T05:33:06Z |
Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia
|
Huang Y.-S.; Liu C.-E.; Lin S.-P.; Lee C.-H.; Yang C.-J.; Lin C.-Y.; Tang H.-J.; Lee Y.-C.; Lin Y.-C.; Lee Y.-T.; HSIN-YUN SUN; Hung C.-C. |
